Supplementary table.
PFASs concentrations in sera (ng/mL) of all patients in this study
| Percent | Percentile | ||||||
| PFASs | LOD | >LOD (%) | Minimum | 25th | Median | 75th | Maximum |
| PFBS | 0.009 | 100 | 0.07 | 0.10 | 0.14 | 0.22 | 2.38 |
| PFHpA | 0.03 | 100 | 0.09 | 0.17 | 0.25 | 0.48 | 0.95 |
| PFHxS | 0.02 | 100 | 0.13 | 0.34 | 0.62 | 1.82 | 4.96 |
| PFOA | 0.09 | 100 | 2.05 | 8.05 | 13.89 | 21.37 | 360.50 |
| PFOS | 0.09 | 100 | 0.73 | 2.48 | 4.47 | 8.26 | 76.76 |
| PFNA | 0.02 | 100 | 0.38 | 0.83 | 1.54 | 2.37 | 15.72 |
| PFDA | 0.02 | 100 | 0.08 | 0.35 | 0.74 | 1.38 | 14.60 |
| PFUA | 0.02 | 100 | 0.03 | 0.20 | 0.51 | 0.75 | 5.22 |
| PFOSA | 0.12 | 46.43 | 0.09 | 0.09 | 0.11 | 0.12 | 0.83 |
| PFDoA | 0.05 | 98.81 | 0.04 | 0.10 | 0.13 | 0.17 | 1.08 |